I am the criminal defense attorney representing Martin Shkreli, the former head of Turing Pharmaceuticals. I represent him in connection with an unrelated securities fraud indictment pending in the U.S. District Court for the Eastern District of New York. Both Shkreli and I have agreed not to speak publicly about that case but rather defend against those charges in a courtroom when appropriate. Accordingly, nothing in this piece is intended to address those charges.
Although I do not represent Turing, I accompanied Shkreli to a hearing held by the U.S. House Committee on Oversight and Government Reform in Washington, D.C., on pharmaceutical pricing that he was compelled to attend in person, despite advance knowledge by the entire committee, that if forced to appear, he would, on advice of counsel, invoke his Fifth Amendment privilege against self-incrimination and would not provide any information. Indeed, in my judgment, the only reason for the committee to compel Shkreli to appear in person was to try to publicly humiliate him.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
